MAPT and ovarian cancer: Statistical significance was achieved in following factors: FIGO stage at diagnosis (p=0.0168), ovarian cancer type (p=0.0166), residual tumor size (p=0.0026), tau expression status (p=0.0198) (Figure 3) and sensitivity to first-line chemotherapy (p<0.0001).